Viewing insider transactions for AstraZeneca PLC's ( LON:AZN ) over the last year, we see that insiders were net...
In the most recent trading session, Astrazeneca (AZN) closed at $79.31, indicating a -0.35% shift from the previous trading day.
The FDA approves AstraZeneca's (AZN) Imfinzi in combination with chemotherapy for treating mismatch repair deficient advanced/recurrent endometrial cancer based on data from the phase III DUO-E study.